ALSO READNatco Pharma dips 12% in two days post Q1 results on profit booking MindTree Q3 result: Deal wins, strong traction in digital are main triggers Natco Pharma's niche portfolio an opportunity Natco Pharma Q1 net doubles to Rs 94 cr on rise in formulation sales Win some, lose some: ICICI Bank Q3 net profit falls 32%, revenues up 10%
Natco Pharma Limited has reported a 11.54 percent increase in net profit at Rs 2.17 billion for the quarter ended December 2017 as compared with Rs 1.95 billion in the corresponding quarter previous year.
However, the revenues declined by 16 percent to Rs 5.74 billion for the quarter under review from Rs 6.85 billion in the year-ago period.
A 32 percent decrease in expenditure at Rs 2.97 billion led by a 50 percent decline in the cost of materials consumed during the quarter helped the company to post profits despite a fall in revenues.
Meanwhile Natco board has declared a second interim dividend of Rs 7 per equity share of a face value of Rs 2 for the year 2017.